These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 26885882)

  • 1. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
    Di Pino A; Urbano F; Zagami RM; Filippello A; Di Mauro S; Piro S; Purrello F; Rabuazzo AM
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease.
    Di Pino A; Urbano F; Scicali R; Di Mauro S; Filippello A; Scamporrino A; Piro S; Purrello F; Rabuazzo AM
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.
    Di Pino A; Currenti W; Urbano F; Scicali R; Piro S; Purrello F; Rabuazzo AM
    Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):978-984. PubMed ID: 28958695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HbA1c Identifies Subjects With Prediabetes and Subclinical Left Ventricular Diastolic Dysfunction.
    Di Pino A; Mangiafico S; Urbano F; Scicali R; Scandura S; D'Agate V; Piro S; Tamburino C; Purrello F; Rabuazzo AM
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3756-3764. PubMed ID: 28973588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients.
    Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Yasuda T; Yamasaki Y
    Diab Vasc Dis Res; 2008 Sep; 5(3):190-7. PubMed ID: 18777492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.
    Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Yasuda T; Umayahara Y; Kosugi K; Yamasaki Y
    Atherosclerosis; 2009 May; 204(1):288-92. PubMed ID: 18926539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c.
    Zagami RM; Di Pino A; Urbano F; Piro S; Purrello F; Rabuazzo AM
    Atherosclerosis; 2015 Dec; 243(2):395-401. PubMed ID: 26520892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between sRAGE, esRAGE levels and vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography.
    Yang SJ; Kim S; Hwang SY; Kim TN; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Atherosclerosis; 2012 Feb; 220(2):402-6. PubMed ID: 22137663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study.
    Heier M; Margeirsdottir HD; Gaarder M; Stensæth KH; Brunborg C; Torjesen PA; Seljeflot I; Hanssen KF; Dahl-Jørgensen K
    Cardiovasc Diabetol; 2015 Sep; 14():126. PubMed ID: 26408307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteria.
    Di Pino A; Scicali R; Calanna S; Urbano F; Mantegna C; Rabuazzo AM; Purrello F; Piro S
    Diabetes Care; 2014 May; 37(5):1447-53. PubMed ID: 24574348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Soluble Receptor for Advanced Glycation End Product and Endogenous Secretory Soluble Receptor for Advanced Glycation End Product Levels and Carotid Atherosclerosis in Diabetes: A Systematic Review and Meta-Analysis.
    Wang X; Wang Q; Wei D; Chang X
    Can J Diabetes; 2021 Oct; 45(7):634-640. PubMed ID: 33773934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
    Kim JK; Park S; Lee MJ; Song YR; Han SH; Kim SG; Kang SW; Choi KH; Kim HJ; Yoo TH
    Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between endogenous secretory RAGE and cardiac autonomic function in prediabetes.
    Dimova R; Chakarova N; Grozeva G; Tankova T
    Int J Clin Pract; 2021 Nov; 75(11):e14769. PubMed ID: 34473880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.
    Loomis SJ; Chen Y; Sacks DB; Christenson ES; Christenson RH; Rebholz CM; Selvin E
    Clin Chem; 2017 May; 63(5):980-989. PubMed ID: 28280052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.
    Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Nakatani Y; Ohtoshi K; Hayaishi-Okano R; Kosugi K; Hori M; Yamasaki Y
    Diabetes Care; 2005 Nov; 28(11):2716-21. PubMed ID: 16249545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes.
    Miranda ER; Somal VS; Mey JT; Blackburn BK; Wang E; Farabi S; Karstoft K; Fealy CE; Kashyap S; Kirwan JP; Quinn L; Solomon TPJ; Haus JM
    Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E631-E640. PubMed ID: 28811295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
    Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
    Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting blood soluble RAGE may be causally implicated in impaired glucose metabolism in Chinese patients with primary hypertension.
    Wang Y; Zhang W; Zhao H; Wang Y; Lu C; Li X; Wang Y; Xiao Y; Wang Y; Wang B
    Gene; 2018 Jan; 639():11-17. PubMed ID: 28974473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.
    Gurecká R; Koborová I; Csongová M; Šebek J; Šebeková K
    Glycoconj J; 2016 Aug; 33(4):599-606. PubMed ID: 27300745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.